Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Noble Mineral highlights Mann West Nickel Sulphide Initial Resource as announced by Canada Nickel June 12, 2025 New INNspired Article Spotlights Rare Earth Recycling as a Strategic Investment Opportunity in U.S. Critical Mineral Supply Chain June 12, 2025 Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases June 12, 2025
Noble Mineral highlights Mann West Nickel Sulphide Initial Resource as announced by Canada Nickel June 12, 2025
New INNspired Article Spotlights Rare Earth Recycling as a Strategic Investment Opportunity in U.S. Critical Mineral Supply Chain June 12, 2025
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases June 12, 2025